<DOC>
	<DOCNO>NCT02129686</DOCNO>
	<brief_summary>This study do evaluate potential benefit use acupuncture reduce symptom tingle , burning , numbness pain hand foot woman peripheral neuropathy completion chemotherapy breast cancer .</brief_summary>
	<brief_title>A Pilot Study Acupuncture Chemotherapy-induced Peripheral Neuropathy Breast Cancer Patients</brief_title>
	<detailed_description>Chemotherapy drug use treat cancer cause temporary permanent damage nerve hand foot , condition call `` chemotherapy-induced peripheral neuropathy '' . The common symptom chemotherapy-induced peripheral neuropathy pain , tingling , burn numbness sensation , lead balance problem trouble use finger pick up/holding thing . These symptom often last month year completion chemotherapy . Medications nutritional supplement ease symptom chemotherapy-induced peripheral neuropathy , many patient continue experience symptom despite treatment . Acupuncture intervention hair-thin , stainless steel needle shallowly insert specific point skin , goal influence body 's natural healing system . Acupuncture study clinical trial cancer patient show effective various condition include chemotherapy-induced nausea vomit . A preliminary study suggest acupuncture may help reduce symptom peripheral neuropathy , information need benefit acupuncture breast cancer patient This study do evaluate potential benefit use acupuncture reduce symptom tingle , burning , numbness pain hand foot woman peripheral neuropathy completion chemotherapy breast cancer . This research study help determine benefit acupuncture treatment chemotherapy-induced peripheral neuropathy . The study also look two different acupuncture schedule determine whether patient derive benefit low high dose acupuncture treatment .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<criteria>History histologically cytologically proven breast cancer stage I , II III , without evidence distant metastasis ; Completed adjuvant taxanebased chemotherapy single agent combination platins HER2 direct therapy Reporting grade 1 great follow symptom persistently 2 week : neuropathic pain , allodynia , areflexia , dysesthesia , paresthesia , hyperesthesia , hypoesthesia glove stock syndrome define Common Terminology Criteria Adverse Events ( CTCAE v. 4.03 ) ( Table 1 screen checklist ) ; Patients currently stable prescription medication dietary supplement CIPN still symptomatic define allow participate study . Related medication : gabapentin , pregabalin , nortriptyline , amitriptyline , duloxetine , venlafaxine ; lidocaine , opioid tramadol narcotic ; NSAIDs ; glutamine , glutathione , vitamin E vitamin B12 ; Age â‰¥ 18 year ; Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 ; Adequate hematological function : neutrophil count &gt; 1.0 x109/L , platelet count &gt; 50x109/L ; Signed informed consent . Patients follow criterion eligible study : Unstable cardiac disease myocardial infarction within 6 month prior study entry ; Wearing pacemaker implantable cardioverterdefibrillator ; uncontrolled seizure disorder ; History preexist peripheral neuropathy prior chemotherapy , include alcoholism , vitamin B deficiency , diabetes , HIV , congenital neuropathy , toxic neuropathy ; Peripheral neuropathy cause tumor infiltration compression spinal nerve surgical trauma ; Pregnancy potential pregnancy nursing ; Active clinically significant uncontrolled infection ; Prior use acupuncture CIPN within 6 month prior study entry ; Patients uncontrolled major psychiatric disorder , major depression psychosis , eligible trial . Patients history depression anxiety stable psychiatric medication eligible .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Chemotherapy-induced peripheral neuropathy ( CIPN )</keyword>
	<keyword>Acupuncture</keyword>
	<keyword>Early-Stage Breast Carcinoma</keyword>
	<keyword>Stage I Breast Cancer</keyword>
	<keyword>Stage II Breast Cancer</keyword>
	<keyword>Stage III Breast Cancer</keyword>
</DOC>